ReleaseWire Connect

An investigation on behalf of investors, who currently hold shares of IGATE Corp (NASDAQ:IGTE), was announced concerning whether the takeover of IGATE Corp by Capgemini for $48 per share is unfair to NASDAQ:IGTE stockholders.

An investigation on behalf of investors of Installed Building Products Inc (NYSE:IBP) shares over potential securities laws violations by Installed Building Products and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors of Endurance International Group Hldgs Inc (NASDAQ:EIGI) shares over potential securities laws violations by Endurance International Group Holdings Inc and certain of its directors and officers in connection certain financial statements was announced.

A deadline is coming up on May 12, 2015 in the lawsuit filed for investors of Inogen Inc (NASDAQ:INGN) over alleged securities laws violations by Inogen.

An investigation on behalf of investors of American Science & Engineering, Inc. (NASDAQ:ASEI) shares over potential securities laws violations by American Science & Engineering certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors of Hanesbrands Inc. (NYSE:HBI) shares over potential securities laws violations by Hanesbrands Inc and certain of its directors and officers in connection certain financial statements was announced.

An investor, who purchased shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Aerie Pharmaceuticals Inc in connection with certain allegedly false and misleading statements made between August 6, 2014 and April 23, 2015.

An investor, who purchased shares of CHC Group Ltd (NYSE:HELI), filed a lawsuit over alleged violations of Securities Laws by CHC Group Ltd, formerly known as FR Horizon Holding (Cayman) Inc, in connection with certain allegedly false and misleading statements in connection with CHC Group Ltd's January 2014 initial public offering.

An investor in Bio-Rad Laboratories, Inc. (NYSE:BIO) filed a petition in effort to get access to certain company records over a $55 million FCPA settlement.

An investigation on behalf of investors of Celladon Corp (NASDAQ:CLDN) shares over potential securities laws violations by Celladon and certain of its directors and officers in connection certain financial statements was announced.